MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

219.40 +6.16 (+2.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
News headline image
Precision Medicine Software Market: Companion Diagnostics Rise ↗
Precision medicine software has moved from a niche research tool to a core piece of modern healthcare infrastructure. As genomic sequencing gets cheaper an 
Via Talk Markets
Topics Artificial Intelligence
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
Waters Q2 Earnings Call Highlights ↗
Waters (NYSE:WAT) reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic... 
Via MarketBeat
Topics Earnings
News headline image
Biotech AI Retail Solutions Market to Reach USD 7.12 Billion by 2034 ↗
According to a new report from Intel Market Research, the global Biotech AI Retail Solutions market was valued at USD 3.45 billion in 2025 and is projected 
Via Talk Markets
Topics Artificial Intelligence
Illumina (NASDAQ:ILMN) Beats Q2 Estimates but Shares Slide 6% After-Hours ↗
Via Chartmill
Illumina (NASDAQ:ILMN) Scores Perfect Technical Rating and High Setup Quality for Breakout Trade ↗
Via Chartmill
News headline image
5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call
Illumina’s second quarter results reflected strong execution in its core clinical sequencing business, with management highlighting robust demand from U.S. a... 
Via StockStory
Topics Earnings
News headline image
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 13.26%. Currently, Illumina has a market capitalization... 
Via Benzinga
News headline image
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after market close. Here’s what to expect. 10x Genomics beat anal... 
Via StockStory
News headline image
PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday afternoon. Here’s what you need to know. PacBio mis... 
Via StockStory
News headline image
Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗
Clinical momentum and NovaSeq X placements drive revenue guidance raise. 
Via The Motley Fool
Topics Earnings
News headline image
3 Cash-Producing Stocks That Concern Us
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70? ↗
The developer of blood-based cancer tests still has a bright future. 
Via The Motley Fool
News headline image
Illumina Q2 Earnings Call Highlights ↗
Illumina (NASDAQ:ILMN) raised its 2026 revenue and earnings outlook after reporting second-quarter results that exceeded its expectations, supported by clinical sequencing demand, elevated NovaSeq X... 
Via MarketBeat
Topics Earnings
News headline image
ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s... 
Via StockStory
News headline image
Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗
Clinical momentum and NovaSeq X placements drive revenue guidance raise. 
Via The Motley Fool
Topics Earnings
News headline image
Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations
Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. ... 
Via StockStory
News headline image
Illumina Earnings: What To Look For From ILMN
Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday after market close. Here’s what to expect. Illumina beat analysts’ ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron... 
Via StockStory
News headline image
3 Profitable Stocks We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. ↗
The fate of Grail's stock will ultimately be decided in the cost-benefit calculations of medical insurers. 
Via The Motley Fool
News headline image
2 Mooning Stocks Worth Investigating and 1 We Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo... 
Via StockStory
Topics Energy
News headline image
Prediction: Grail Stock Will Skyrocket to $100 in 1 Year ↗
The cancer test maker still has a bright future. 
Via The Motley Fool
News headline image
3 Mid-Cap Stocks That Concern Us
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
Why Illumina (ILMN) Stock Is Down Today
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge... 
Via StockStory
News headline image
Why Illumina (ILMN) Stock Is Trading Up Today
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to ... 
Via StockStory
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗
Grail is on a quest to win in a $50 billion market. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story